Jian Tian Selected Research

Heart Failure

1/2022	Assessment of causal direction between thyroid function and cardiometabolic health: a Mendelian randomization study.
11/2019	Implications of N-terminal pro-B-type natriuretic peptide in patients with three-vessel disease.
2/2019	Efficacy and safety of levothyroxine (L-T4) replacement on the exercise capability in chronic systolic heart failure patients with subclinical hypothyroidism: Study protocol for a multi-center, open label, randomized, parallel group trial (ThyroHeart-CHF).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jian Tian Research Topics

Disease

13	Neoplasms (Cancer) 05/2023 - 11/2013
9	Osteoarthritis 01/2022 - 01/2013
5	Fibrosis (Cirrhosis) 01/2023 - 01/2010
4	Acute Coronary Syndrome 12/2023 - 01/2020
4	Knee Osteoarthritis 11/2016 - 01/2013
3	Myocardial Infarction 01/2022 - 07/2018
3	Heart Failure 01/2022 - 02/2019
3	Type 2 Diabetes Mellitus (MODY) 01/2022 - 11/2016
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 01/2017
3	Osteoporosis 04/2021 - 06/2011
3	Thrombosis (Thrombus) 01/2020 - 07/2018
3	Osteosarcoma (Osteogenic Sarcoma) 01/2020 - 10/2014
3	Breast Neoplasms (Breast Cancer) 07/2019 - 01/2016
3	Bone Resorption 06/2012 - 06/2011
2	Tendon Injuries 05/2024 - 02/2024
2	Tissue Adhesions 05/2024 - 01/2023
2	Atherosclerosis 01/2024 - 01/2020
2	Wounds and Injuries (Trauma) 01/2024 - 01/2023
2	Hyperlipidemias (Hyperlipidemia) 01/2022 - 01/2013
2	Hypertension (High Blood Pressure) 01/2022 - 01/2020
2	Stroke (Strokes) 01/2022 - 04/2016
2	Death (Near-Death Experience) 01/2022 - 11/2019
2	Coronary Disease (Coronary Heart Disease) 07/2020 - 06/2018
2	Obesity 01/2020 - 01/2013
2	Inflammation (Inflammations) 01/2020 - 01/2013
2	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2019
2	Carcinogenesis 01/2020 - 10/2014
2	Hyperuricemia 05/2019 - 02/2017
2	Prostatic Neoplasms (Prostate Cancer) 06/2014 - 04/2005
2	Pathologic Processes 02/2004 - 04/2003
1	Myalgia 03/2024
1	Hyperthermia 12/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2023
1	Insulin Resistance 12/2023
1	Stable Angina 12/2023
1	Radiation Fibrosis Syndrome (Radiation Fibrosis) 01/2023
1	Wound Infection (Wound Infections) 01/2023
1	Colorectal Neoplasms (Colorectal Cancer) 01/2023
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022
1	Essential Hypertension 01/2022
1	Pulmonary Heart Disease (Cor Pulmonale) 01/2022
1	Acute Disease 01/2022

Drug/Important Bio-Agent (IBA)

6	OsteopontinIBA 08/2020 - 01/2013
5	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2019
4	CateninsIBA 01/2023 - 10/2014
3	RNA (Ribonucleic Acid)IBA 05/2024 - 10/2014
3	Messenger RNA (mRNA)IBA 02/2024 - 01/2013
3	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2023 - 06/2014
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 02/2017
3	LipidsIBA 04/2021 - 02/2019
3	SmokeIBA 06/2012 - 06/2011
2	Proteins (Proteins, Gene)FDA Link 03/2024 - 01/2010
2	C-Reactive ProteinIBA 03/2024 - 01/2022
2	omega-Chloroacetophenone (Mace)IBA 12/2023 - 01/2020
2	Glucose (Dextrose)FDA LinkGeneric 12/2023 - 01/2021
2	PorphyrinsIBA 05/2023 - 04/2021
2	LigandsIBA 05/2023 - 01/2013
2	Oxygen (Dioxygen)IBA 05/2023 - 01/2019
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 05/2023 - 07/2019
2	CytokinesIBA 01/2023 - 11/2016
2	Therapeutic UsesIBA 02/2022 - 01/2019
2	Metal-Organic FrameworksIBA 02/2022 - 04/2021
2	pro-brain natriuretic peptide (1-76)IBA 11/2019 - 02/2019
2	CollagenIBA 01/2013 - 07/2009
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 03/2024
1	Interleukin-6 (Interleukin 6)IBA 03/2024
1	Malondialdehyde (Propanedial)IBA 03/2024
1	Creatine Kinase (Creatine Phosphokinase)IBA 03/2024
1	Oxidoreductases (Dehydrogenase)IBA 01/2024
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2024
1	Ezetimibe (Zetia)FDA Link 01/2024
1	3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA 01/2024
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2024
1	MetalsIBA 01/2024
1	Peroxidase (Myeloperoxidase)IBA 01/2024
1	Contrast MediaIBA 12/2023
1	Triglycerides (Triacylglycerol)IBA 12/2023
1	corroleIBA 01/2023
1	Dicumarol (Dicoumarol)FDA Link 01/2023
1	Aquaporins (Water Channels)IBA 01/2023
1	Aquaporin 1IBA 01/2023
1	ChitosanIBA 01/2023
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2023
1	Cisplatin (Platino)FDA LinkGeneric 02/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2022
1	PolymersIBA 02/2022
1	1- ethynyl- 4- hydroperoxy- 1,2,3,4- tetrahydro- 1- naphtholIBA 01/2022
1	HydrogelsIBA 01/2022
1	Biopolymers (Biopolymer)IBA 01/2022

Therapy/Procedure

10	Therapeutics 05/2024 - 01/2016
4	Percutaneous Coronary Intervention 01/2022 - 01/2017
4	Stents 01/2021 - 07/2018
3	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2022 - 06/2018
2	Conscious Sedation 01/2021 - 07/2020
2	Drug-Eluting Stents 01/2020 - 12/2018
1	Immunotherapy 02/2024
1	Phototherapy (Light Therapy) 05/2023
1	Intravenous Injections 05/2023
1	Photochemotherapy (Photodynamic Therapy) 05/2023
1	Combination Drug Therapy (Combination Chemotherapy) 02/2022